Skip to content Skip to footer
0 items - $0.00 0
Complete Omics
0 items - $0.00 0
Complete Omics

Valid-NEO

Close
<h3>Breaking the “Undruggable”: TP53 Neoantigens Identified</h3> <p> <em><strong>Science</strong></em>.…
Valid-NEO
<h3>Breaking the “Undruggable”: KRAS Neoantigens Identified</h3> <p> <em><strong>Science…
Valid-NEO
<h3>Unlocking a New Class of Cancer Targets: HERV Neoantigens</h3> <p>…
Valid-NEO
<h3>Prediction-Free, Totally Data-Driven Neoantigen Discovery: The Valid-NEO Platform</h3> <p> …
Valid-NEO
<h3>Expanding Immunotherapy Targets: Shared Graft-Versus-Leukemia Antigens Identified</h3> <p> …
Valid-NEO
<h3>First Direct Detection of Cancer Neoantigens: The Prototype of Valid-NEO</h3>…
Valid-NEO
<h3>Opening New Immunotherapy Targets: HERV-Derived Tumor Epitopes in Ovarian Cancer</h3>…
Valid-NEO